Showing results (1-10 of 12) with videos related to
Sort By:
Pageof 2
Seminars in Neurology|March 30, 2019
Autoimmune Encephalitides and Rapidly Progressive DementiasSarah F Wesley, Damien FergusonNeurology. Clinical Practice|March 9, 2018
Practice Current: When do you suspect autoimmune encephalitis and what is the role of antibody testing?Aravind Ganesh, Sarah F WesleyClinical Neurology and Neurosurgery|October 2, 2019
Meningoradiculitis and transaminitis from neuroborreliosis: A case of variant Bannwarth syndromeMonica M Diaz, Sarah F WesleyNeurology. Clinical Practice|April 21, 2020
Worldwide survey of neurologists on approach to autoimmune encephalitisAravind Ganesh, Luca Bartolini, Sarah F WesleyNeurology. Clinical Practice|September 6, 2021
Neuroinflammation Associated With Tumor Necrosis Factor-α Inhibitor ExposureAmy W Yu, Maggie Pecsok, Erin E Longbrake, et al.International Journal of Molecular Sciences|July 2, 2021
Neurological Immunotoxicity from Cancer TreatmentSarah F Wesley, Aya Haggiagi, Kiran T Thakur, et al.Journal of Child Neurology|May 15, 2025
Surviving Grade 4 ICANS: A Case Report and Discussion of Emerging Management StrategiesAlexander J Jonokuchi, Amy W Yu, Gurcharanjeet Kaur, et al.JTO Clinical and Research Reports|September 30, 2021
Intracranial Complications From Immune Checkpoint Therapy in a Patient With NSCLC and Multiple Sclerosis: Case ReportBenjamin Y Lu, Cigdem Isitan, Amit Mahajan, et al.Journal of the Academy of Consultation-Liaison Psychiatry|February 19, 2025
Developing a Clinical Workflow for Early Recognition and Diagnosis of Autoimmune Encephalitis in Patients Presenting With Atypical PsychosisGrace Russo, Lucy Jia, Carla Y Kim, et al.Journal of Immunotherapy (Hagerstown, Md. : 1997)|April 11, 2022
Axicabtagene Ciloleucel in Patients Ineligible for ZUMA-1 Because of CNS Involvement and/or HIV: A Multicenter ExperienceCarlen A Yuen, Jing-Mei Hsu, Koen Van Besien, et al.Pageof 2